摘要
目的:轻度认知障碍(MCI)通常是正常老化与阿尔茨海默病(AD)之间的过渡状态。当纵向观察时,一些MCI患者转化为AD,而另一部分仍然保持MCI或恢复正常的功能状态。这种分歧为具有不同结果的MCI患者的静息状态大脑活动中表现出潜在的生物标志物提供了一些启示。最近的研究表明,AD / MCI患者除了典型的记忆障碍外,其他执行功能也会受损。这个观察得出了一个问题,即执行控制网络(ECN)支持中央执行功能是否受损。鉴于有效连接性是检测AD / MCI中的静息脑异常的足够指标,本研究特别提出了一个问题,即在不同的post-hoc标签的MCI患者中有效的连接方式是否有区别。 方法:我们根据纵向获得的进展状态将MCI受试者分为3组:1)15例MCI-R受试者:MCI恢复正常功能状态,并在24个月内稳定至正常状态; 2)35例MCI-S受试者:MCI患者将该疾病保持稳定24个月; 3)22例MCI-P受试者:MCI进展到AD,并在24个月内稳定为AD,4)39例年龄匹配的正常对照受试者(NC)。我们在使用独立成分分析的所有科目中确定了ECN的核心节点后,进行了Granger因果关系分析。我们的研究结果显示,与NC组相比,不同的MCI组在ECN内呈现出不同的有效连接模式。具体来说,(1)背外侧前额叶皮质(dLPFC)和内侧前额叶皮层(mPFC)是ECN网络中呈现不同连接模式的核心节点; (2)ECN中有效连接电路“R.dLPFC→右尾状→左丘脑→R.dLPFC”显示不同程度的损伤;和(3)R.dLPFC和L.LP之间有四条途径,这四条途径也不同。 结果:我们的结果有助于了解MCI患者的潜在中心机制。 ECN的差异化有效连接可能是早期检测AD的潜在生物标志物,也可为临床研究人员提供一个参考,为临床研究人员操纵有不同风险的MCI患者的活动具有独特的干预措施。
关键词: 有效连接,格兰杰因果关系分析,执行控制网络,逐步MCI,休息状态,独立成分分析,生物标志物。
Current Alzheimer Research
Title:Differentiated Effective Connectivity Patterns of the Executive Control Network in Progressive MCI: A Potential Biomarker for Predicting AD
Volume: 14 Issue: 9
关键词: 有效连接,格兰杰因果关系分析,执行控制网络,逐步MCI,休息状态,独立成分分析,生物标志物。
摘要: Objective: Mild cognitive impairment (MCI) is often a transitional state between normal aging and Alzheimer’s disease (AD). When observed longitudinally, some MCI patients convert to AD, while a considerable portion either remains MCI or revert to a normal functioning state. This divergence has provided some enlightenment on a potential biomarker to be represented in the resting state brain activities of MCI patients with different post-hoc labels. Recent studies have shown impaired executive functions, other than typically explicated memory impairment with AD/MCI patients. This observation raises the question that whether or not the executive control network (ECN) was impaired, which pivotally supports the central executive functions. Given the fact that effective connectivity is a sufficient index in detecting resting brain abnormalities in AD/MCI, the current study specifically asks a question whether the effective connectivity patterns are differentiated in MCI patients with different post-hoc labels.
Methods: We divided the MCI subjects into three groups depending on their progressive state obtained longitudinally: 1) 15 MCI-R subjects: MCI reverted to the normal functioning state and stabilized to the normal state in 24 months; 2) 35 MCI-S subjects: MCI patients maintained this disease in a stable state for 24 months; 3) 22 MCI-P subjects: MCI progressed to AD and stabilized to AD in 24 months, and 4) 39 age-matched normal control subjects (NC). We conducted a Granger causality analysis after identifying the core nodes of ECN in all of the subjects using Independent Component Analysis. Our findings revealed that different MCI groups presented different effective connectivity patterns within the ECN compared to the NC group. Specifically, (1) dorsolateral prefrontal cortex (dLPFC) and medial prefrontal cortex (mPFC) were the core nodes in the ECN network that exhibited different connecting patterns; (2) an effective connection circuit “R.dLPFC→ right caudate→ left thalamus→R.dLPFC” in the ECN showed different levels of damage; and (3) there were four pathways between the R.dLPFC and L.LP, and these four pathways were also different. Results: Our results would help to understand the potential central mechanism of MCI patients. The differentiated effective connectivity of ECN may serve as a potential biomarker for early detection of AD, which may also provide a reference for clinical researchers to manipulate active but distinctive interventions for MCI patients who have different risks.Export Options
About this article
Cite this article as:
Differentiated Effective Connectivity Patterns of the Executive Control Network in Progressive MCI: A Potential Biomarker for Predicting AD, Current Alzheimer Research 2017; 14 (9) . https://dx.doi.org/10.2174/1567205014666170309120200
DOI https://dx.doi.org/10.2174/1567205014666170309120200 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Triazino-caffeine Derivatives by Intramolecular Cyclization: Synthesis, Characterization and Antimicrobial Studies
Letters in Organic Chemistry Tissue-Based Approaches to Study Pharmacodynamic Endpoints in Early Phase Oncology Clinical Trials
Current Drug Targets Thirty Years of Dutch Drugs and Driving Research: Strengths and Limitations of the On-The-Road Highway Driving Test and Future Challenges
Current Psychopharmacology Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study
Current Stem Cell Research & Therapy Molecular Mechanisms of Bioprotection Process by Trehalose
Current Nutrition & Food Science Comparative Effectiveness of Agmatine and Choline Treatment in Rats with Cognitive Impairment Induced by AlCl<sub>3</sub> and Forced Swim Stress
Current Clinical Pharmacology Recent Developments of Structure Based β-Secretase Inhibitors for Alzheimers Disease
Current Topics in Medicinal Chemistry Children and War: A Personal Perspective on Childhood in World War II and Post-war Germany
Adolescent Psychiatry Methadone Maintenance Treatment and Cognitive Function: A Systematic Review
Current Drug Abuse Reviews Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders
Central Nervous System Agents in Medicinal Chemistry Biomedical Applications of Protein Microarrays
Current Medicinal Chemistry Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway
Central Nervous System Agents in Medicinal Chemistry Child and Adolescent Mental Health in Pakistan
Adolescent Psychiatry Psychosocial Vulnerability and Early Life Adversity as Risk Factors for Central Sensitivity Syndromes
Current Rheumatology Reviews A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists
Current Pharmaceutical Design Pituitary Adenylate Cyclase Activating Polypeptide in Animal Models of Neurodegenerative Disorders - Implications for Huntington and Parkinsons Diseases
Letters in Drug Design & Discovery Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer
Current Cancer Therapy Reviews Design and Development of ChemInfoCloud: An Integrated Cloud Enabled Platform for Virtual Screening
Combinatorial Chemistry & High Throughput Screening Intravenous Immunoglobulin Reduces Tau Pathology and Preserves Neuroplastic Gene Expression in the 3xTg Mouse Model of Alzheimer`s Disease
Current Alzheimer Research Non-Antidepressant Treatment of Social Anxiety Disorder: A Review
Current Clinical Pharmacology